Haverkamp W - Search Results

1

Antiarrhythmic properties of beta-blockers.

Haverkamp W, Hindricks G, Gülker H. Haverkamp W, et al. J Cardiovasc Pharmacol. 1990;16 Suppl 5:S29-32. J Cardiovasc Pharmacol. 1990. PMID: 11527133 Review.

2

How to evaluate class III antiarrhythmic drug efficacy clinically: the benefits and shortcomings of the invasive approach.

Borggrefe M, Haverkamp W, Shenasa M, Hindricks G, Breithardt G. Borggrefe M, et al. Among authors: haverkamp w. J Cardiovasc Pharmacol. 1992;20 Suppl 2:S32-40. J Cardiovasc Pharmacol. 1992. PMID: 1279307 Review.

3

Sodium channel blockers in the treatment of ventricular arrhythmias: different effects in the normal, ischaemic or failing heart?

Haverkamp W, Hindricks G, Fechtrup C, Borggrefe M, Breithardt G. Haverkamp W, et al. Eur Heart J. 1991 Dec;12 Suppl F:10-7. doi: 10.1093/eurheartj/12.suppl_f.10. Eur Heart J. 1991. PMID: 1666550 Review.

4

Effects of beta-blockade on the incidence of ventricular tachyarrhythmias during acute myocardial ischemia: experimental findings and clinical implications.

Haverkamp W, Gülker H, Hindricks G, Breithardt G. Haverkamp W, et al. Basic Res Cardiol. 1990;85 Suppl 1:293-303. doi: 10.1007/978-3-662-11038-6_24. Basic Res Cardiol. 1990. PMID: 1982610 Review.

5

Electrophysiologic, haemodynamic and antiarrhythmic effects of the new class Ic agent 1-(2'-biphenyloxy)-2-tert.-butylamino-propanol-2-hydrochloride.

Chiladakis I, Hindricks G, Haverkamp W, Vogt J, Gülker H. Chiladakis I, et al. Among authors: haverkamp w. Arzneimittelforschung. 1989 Sep;39(9):1130-2. Arzneimittelforschung. 1989. PMID: 2590263

6

Comparative investigations on the antiarrhythmic and electrophysiologic effects of class I-IV antiarrhythmic agents following acute coronary artery occlusion.

Thale J, Haverkamp W, Hindricks G, Gülker H. Thale J, et al. Among authors: haverkamp w. Eur Heart J. 1987 Oct;8 Suppl G:91-8. doi: 10.1093/eurheartj/8.suppl_g.91. Eur Heart J. 1987. PMID: 3443133

7

Use of diprafenone, a new potent propafenone-analogue, in acute experimental myocardial ischaemia and infarction.

Thale J, Gülker H, Hindricks G, Haverkamp W, Bender F. Thale J, et al. Among authors: haverkamp w. Eur Heart J. 1987 Aug;8 Suppl D:107-15. doi: 10.1093/eurheartj/8.suppl_d.107. Eur Heart J. 1987. PMID: 3678251

8

Comparative investigations on the antiarrhythmic and electrophysiological effects of various calcium antagonists (diltiazem, verapamil, gallopamil, nifedipine) following acute transient coronary artery occlusion and reperfusion.

Haverkamp W, Thale J, Gülker H, Hindricks G, Bender F. Haverkamp W, et al. Eur Heart J. 1987 Aug;8 Suppl D:117-28. doi: 10.1093/eurheartj/8.suppl_d.117. Eur Heart J. 1987. PMID: 3678252

9

The role of the ICD in patients with dilated and hypertrophic cardiomyopathy.

Borggrefe M, Chen X, Block M, Haverkamp W, Hindricks G, Shenasa M, Breithardt G. Borggrefe M, et al. Among authors: haverkamp w. Pacing Clin Electrophysiol. 1992 Apr;15(4 Pt 3):616-26. doi: 10.1111/j.1540-8159.1992.tb05151.x. Pacing Clin Electrophysiol. 1992. PMID: 1375360 No abstract available.

10

Catheter ablation using radiofrequency energy.

Borggrefe M, Hindricks G, Haverkamp W, Breithardt G. Borggrefe M, et al. Among authors: haverkamp w. Clin Cardiol. 1990 Feb;13(2):127-31. doi: 10.1002/clc.4960130212. Clin Cardiol. 1990. PMID: 2407395 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

417 results

Search Page

Filters